Sarcoma: all 1,691 studies

Page 9 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTerminatedNCT05275478Phase 1/2
• Economic Evaluation of Sarcoma Patients Management in FranceStatus unknownNCT05272358
• Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy SensitizationSuspendedNCT05264974Phase 1
• Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade SarcomaTerminatedNCT05262101Phase 2
• A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsActive, not recruitingNCT05238883Phase 1
• SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
• Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02）CompletedNCT05235100Phase 2
• A Study of HFB301001 in Adult Patients With Advanced Solid TumorsTerminatedNCT05229601Phase 1
• Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
• Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With SarcomaCompletedNCT05216029Not applicable
• A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
• A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic SarcomaStatus unknownNCT05193214Phase 2
• HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue SarcomasActive, not recruitingNCT05180695Phase 1/2
• Niraparib for the Treatment of LeiomyosarcomaWithdrawnNCT05174455Phase 2
• Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue SarcomaStatus unknownNCT05171413
• A Study of PRT2527 in Participants With Advanced Solid TumorsCompletedNCT05159518Phase 1
• Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant TumorsTerminatedNCT05154630Phase 1/2
• Fruquintinib in the Treatment of Soft Tissue SarcomaStatus unknownNCT05142631Phase 2
• A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaStatus unknownNCT05138146Phase 2
• The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
• CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive SarcomasTerminatedNCT05128786Phase 1
• Proton Pencil Beam Scanning GRID for Treatment of Bulky TumorsActive, not recruitingNCT05121545Not applicable
• A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue SarcomaStatus unknownNCT05121350Phase 3
• Phase 2 Study of 9-ING-41 With Chemotherapy in SarcomaWithdrawnNCT05116800Phase 2
• Sarcomas and DDR-Inhibition; a Combined Modality StudyTerminatedNCT05116254Phase 1
• Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid TumoursCompletedNCT05114668Phase 1
• Hypofractionated vs Conventional Fractionated RT in Soft Tissue SarcomasSuspendedNCT05109494Phase 2
• Surufatinib in Patients With Osteosarcoma and Soft Tissue SarcomaActive, not recruitingNCT05106777Phase 2
• The Prognostic Value of Serum Biomarkers in Ewing's SarcomaCompletedNCT05100368
• Lurbinectedin + Doxorubicin In LeiomyosarcomaActive, not recruitingNCT05099666Phase 1/2
• Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsActive, not recruitingNCT05075993Phase 1
• Retroperıtoneal Soft-Tıssue SarcomasCompletedNCT05044624Not applicable
• Camsirubicin + Pegfilgrastim to Determine MTD in ASTSTerminatedNCT05043649Phase 1
• Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing SarcomaWithdrawnNCT05042934Phase 1/2
• Analysis of the Molecular Profile of the Mixofibrosarcoma of the ExtremitiesCompletedNCT04991883
• A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursActive, not recruitingNCT04969835Phase 1
• Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)Active, not recruitingNCT04968106Phase 2
• FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss TumorsTerminatedNCT04965753Phase 1
• Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall.Status unknownNCT04960332Not applicable
• Drug Sensitivity and Mutation ProfilingCompletedNCT04956198
• Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With IonsActive, not recruitingNCT04946357Not applicable
• Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental SimulationCompletedNCT04911972
• Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue SarcomaStatus unknownNCT04910126Phase 2
• A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasWithdrawnNCT04906876Phase 2
• Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompletedNCT04902872Phase 1/2
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue SarcomaTerminatedNCT04900766Phase 1
• Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)Active, not recruitingNCT04893356
• Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid TumorsSuspendedNCT04890093Phase 1/2
• Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary MetastasesCompletedNCT04887298Phase 1/2
• Gemcitabine With Ascorbate Including AdolescentsWithdrawnNCT04877587Early Phase 1
• Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced SarcomaActive, not recruitingNCT04874311Phase 2
• Cemiplimab for Secondary AngiosarcomasCompletedNCT04873375Phase 2
• Indo-cyanine Green (ICG) in Paediatric Oncology MISCompletedNCT04854018Phase 4
• A Study of Different Dosing Schedules of Selinexor in Sarcoma PatientsCompletedNCT04811196Phase 1
• Targeting ATR in Soft-tissue SarcomasCompletedNCT04807816Phase 2
• Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.CompletedNCT04802070Phase 1
• A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid TumorsWithdrawnNCT04791228Phase 2
• A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue SarcomaTerminatedNCT04780464Phase 3
• Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue SarcomaStatus unknownNCT04765228Phase 2
• Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue SarcomaActive, not recruitingNCT04733183Phase 2
• A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsTerminatedNCT04725331Phase 1/2
• Combining Epigenetic And Immune Therapy to Beat Cancer.CompletedNCT04705818Phase 2
• TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN LossStatus unknownNCT04690725Phase 1/2
• A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsActive, not recruitingNCT04673942Phase 2
• A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Active, not recruitingNCT04671693Not applicable
• Cabozantinib With Topotecan-CyclophosphamideCompletedNCT04661852Phase 1
• Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in ChildrenStatus unknownNCT04659733Phase 1
• Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly PatientsTerminatedNCT04656262Phase 3
• Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
• Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)Active, not recruitingNCT04634227Early Phase 1
• First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue SarcomaCompletedNCT04619056Phase 1
• In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsActive, not recruitingNCT04616248Phase 1
• Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue SarcomaStatus unknownNCT04606108Phase 2
• Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)Active, not recruitingNCT04595747Phase 2
• To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft TissueCompletedNCT04593758Phase 1/2
• Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyCompletedNCT04593277Not applicable
• Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma SurgeonsWithdrawnNCT04553744
• Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue SarcomaActive, not recruitingNCT04551430Phase 2
• Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesActive, not recruitingNCT04541108Early Phase 1
• Prehabilitation Soft-Tissue Sarcoma of Lower LimbStatus unknownNCT04518488Not applicable
• Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?CompletedNCT04512495Not applicable
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT04483778Phase 1
• ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or MyxofibrosarcomaActive, not recruitingNCT04480502Phase 2
• Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
• 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With SarcomaActive, not recruitingNCT04457258Early Phase 1
• A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPSStatus unknownNCT04447274Phase 2
• Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyActive, not recruitingNCT04430725
• Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue SarcomasActive, not recruitingNCT04425967Not applicable
• Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaActive, not recruitingNCT04420975Phase 1
• Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced SarcomasCompletedNCT04398095Not applicable
• Pharmacometabolomic of Trabectedin in Soft Tissue PatientsCompletedNCT04394728
• Evolutionary Therapy for RhabdomyosarcomaActive, not recruitingNCT04388839Phase 2
• Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue TumorsCompletedNCT04377360Not applicable
• Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.CompletedNCT04367779
• The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaStatus unknownNCT04356872Phase 2
• Translation and Validation of the German Version of the Toronto Extremity Salvage Score (TESS) and Musculoskeletal Tumor Society (MSTS)Status unknownNCT04327908
• TAEST16001 in the Treatment of Soft Tissue SarcomaStatus unknownNCT04318964Phase 1
• Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver TumorsTerminatedNCT04315883
• Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper EgyptCompletedNCT04300179
• Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and LegsActive, not recruitingNCT04288375Phase 2

← Sarcoma overview